ProfileGDS4718 / 223213_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 86% 86% 86% 88% 83% 73% 87% 89% 87% 86% 86% 73% 84% 83% 85% 88% 84% 73% 81% 84% 85% 88% 87% 85% 81% 90% 82% 88% 74% 86% 78% 86% 88% 79% 76% 84% 86% 86% 86% 87% 82% 76% 79% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6707186
GSM549102patient 115, normal, homogenized [OPG study]8.4871486
GSM549104patient 119, normal, homogenized [OPG study]8.6486486
GSM549108patient 138, normal, homogenized [OPG study]8.4505286
GSM549119patient 077, normal, homogenized [OPG study]8.9511288
GSM549133patient 032, cancer, homogenized [OPG study]8.3747683
GSM549139patient 042, cancer, homogenized [OPG study]7.2035773
GSM549099patient 107, normal, homogenized [OPG study]8.6372187
GSM549109patient 139, normal, homogenized [OPG study]9.0735589
GSM549110patient 046, normal, homogenized [OPG study]8.7362787
GSM549114patient 063, normal, homogenized [OPG study]8.7563786
GSM549122patient 082, normal, homogenized [OPG study]8.652186
GSM549134patient 033, cancer, homogenized [OPG study]7.1111373
GSM549136patient 036, cancer, homogenized [OPG study]8.4504984
GSM549140patient 044, cancer, homogenized [OPG study]8.3388183
GSM549111patient 047, normal, homogenized [OPG study]8.5812985
GSM549113patient 057, normal, homogenized [OPG study]9.0879688
GSM549132patient 031, cancer, homogenized [OPG study]8.3355484
GSM549137patient 038, cancer, homogenized [OPG study]7.2135573
GSM549142patient 047, cancer, homogenized [OPG study]7.7157181
GSM549100patient 110, normal, homogenized [OPG study]8.2782784
GSM549107patient 135, normal, homogenized [OPG study]8.4577285
GSM549115patient 068, normal, homogenized [OPG study]9.0900288
GSM549116patient 072, normal, homogenized [OPG study]8.8318487
GSM549120patient 078, normal, homogenized [OPG study]8.4744385
GSM549131patient 030, cancer, homogenized [OPG study]8.0891981
GSM549118patient 074, normal, homogenized [OPG study]9.2174190
GSM549129patient 027, cancer, homogenized [OPG study]8.0767882
GSM549123patient 088, normal, homogenized [OPG study]8.8571888
GSM549124patient 006, cancer, homogenized [OPG study]7.1422574
GSM549126patient 015, cancer, homogenized [OPG study]8.6193986
GSM549128patient 025, cancer, homogenized [OPG study]7.6928578
GSM549103patient 117, normal, homogenized [OPG study]8.4307186
GSM549117patient 073, normal, homogenized [OPG study]9.0263588
GSM549138patient 041, cancer, homogenized [OPG study]7.8194379
GSM549141patient 045, cancer, homogenized [OPG study]7.5174876
GSM549130patient 028, cancer, homogenized [OPG study]8.321884
GSM549101patient 111, normal, homogenized [OPG study]8.5621986
GSM549105patient 128, normal, homogenized [OPG study]8.4921286
GSM549106patient 134, normal, homogenized [OPG study]8.7850386
GSM549112patient 048, normal, homogenized [OPG study]8.8306387
GSM549125patient 011, cancer, homogenized [OPG study]8.0920582
GSM549127patient 024, cancer, homogenized [OPG study]7.5011876
GSM549135patient 035, cancer, homogenized [OPG study]7.8965279